- Home
- Articles
-
10.5606/tgkdc.dergisi.2021.21284
Raising the bar to ultradisciplinary collaborations in management of chronic thromboembolic pulmonary hypertension
Tankut Akay1, Cihangir Kaymaz2, Ahmet Rüçhan Akar3, Gökçen Orhan4, Mehmed Yanartaş5, Bahadır Gültekin1, Mustafa Şırlak3, Ümit Kervan6, Serpil Gezer Taş7, Murat Biçer8, Tahir Yağdı9, Selim İspir10, Rıza Doğan11
1Department of Cardiovascular Surgery, Başkent University Faculty of Medicine Ankara Hospital, Ankara, Turkey
2Department of Cardiology, University of Health Sciences, Hamidiye Medical Faculty, Koşuyolu Heart Center, Istanbul, Turkey
3Department of Cardiovascular Surgery, Ankara University Faculty of Medicine, Ankara, Turkey
4Department of Cardiovascular Surgery, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul, Turkey
5Department of Cardiovascular Surgery, Çam ve Sakura Hospital, Istanbul, Turkey
6Department of Cardiovascular Surgery, University of Health Sciences, Ankara City Hospital, Ankara, Turkey
7Department of Cardiovascular Surgery, University of Health Sciences Hamidiye Medical Faculty, Koşuyolu Heart Center, İstanbul, Turkey
8Department of Cardiovascular Surgery, Uludağ University Faculty of Medicine, Bursa, Turkey
9Department of Cardiovascular Surgery, Ege University Faculty of Medicine, Izmir, Turkey
10Department of Cardiovascular Surgery, Acıbadem University Faculty of Medicine, Istanbul, Turkey
11Department of Cardiovascular Surgery, Hacettepe University Faculty of Medicine, Ankara, Turkey
DOI : 10.5606/tgkdc.dergisi.2021.21284
Chronic thromboembolic pulmonary hypertension is an underdiagnosed
and potentially fatal subgroup of pulmonary hypertension, if left
untreated. Clinical signs include exertional dyspnea and non-specific
symptoms. Diagnosis requires multimodality imaging and heart
catheterization. Pulmonary endarterectomy, an open heart surgery, is
the gold standard treatment of choice in selected patients in specialized
centers. Targeted medical therapy and balloon pulmonary angioplasty
can be effective in high-risk patients with significant comorbidities, distal
pulmonary vascular obstructions, or recurrent/persistent pulmonary
hypertension after pulmonary endarterectomy. Currently, there is a
limited number of data regarding novel coronavirus-2019 infection in
patients with chronic thromboembolic pulmonary hypertension and the
changing spectrum of the disease during the pandemic. Challenging
times during this outbreak due to healthcare crisis and relatively higher
case-fatality rates require convergence; that is an ultradisciplinary
collaboration, which crosses disciplinary and sectorial boundaries
to develop integrated knowledge and new paradigms. Management
strategies for the "new normal" such as virtual care, preparedness
for further threats, redesigned standards and working conditions,
reevaluation of specific recommendations, and online collaborations for
optimal decisions for chronic thromboembolic pulmonary hypertension
patients may change the poor outcomes.
Keywords : Balloon pulmonary angioplasty, chronic thromboembolic pulmonary hypertension, pulmonary endarterectomy, pulmonary thromboembolism, targeted medical therapy
Viewed : 2905
Downloaded : 524